C. Schwarz
ORCID: 0000-0003-3474-2857Also affiliated with University of Applied Sciences Potsdam, Cystic Fibrosis Research Foundation, Klinikum Oldenburg, Klinikum Ernst von Bergmann
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 3 papers. Top paper: “Safety and efficacy of vanzacaftor–tezacaftor–deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trials”.
Gordon MacGregor, Pilar Azevedo, V. Indihar, Claire Keating, Marcus Mall +77 more
Effects of CYP7A1 overexpression on cholesterol and bile acid homeostasis
C. Schwarz, P. B. Hylemon, D. Mallonee, K. Valerie, D. M. Heuman +4 more
Sivagurunathan Sutharsan, Ralph Epaud, Ross C. Klingsberg, Rainald Fischer, Steven M. Rowe +7 more